홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

2-(2-Amino-6-methoxypurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

HCID 248862
새 반응
인쇄
기본 정보이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
121032-29-9
표준 SMILES
COc1nc(N)nc2c1ncn2C1OC(CO)C(O)C1O
InChIKey
IXOXBSCIXZEQEQ-UHFFFAOYSA-N
분자식
C11H15N5O5
평균 분자량
297.27 g/mol
단동위원소 질량
297.1073186

이름 및 식별자

우선 이름
2-(2-Amino-6-methoxypurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
IUPAC
2-(2-amino-6-methoxypurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
영어명
Nelarabine
분자식
C11H15N5O5
분자량
297.27

이름 및 동의어

NSC-66381RefChem:115360434793-34-5MFCD01723912S12132-(2-amino-6-methoxypurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diolCHEMBL1513356SCHEMBL13657986SCHEMBL29401939(2R,3R,4R,5R)-2-(2-amino-6-methoxy-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diolHMS3654B03HMS5079I17
이름 더 보기
MAYArranonNELARABINNelzarabine506u506U78CS-1953GW 506U78NELARABINENelarabine D4
(2R,3R,4S,5R)-2-(2-amino-6-methoxy-9H-purin-9-yl)-5-(hydroxymethyl)-tetrahydrofuran-3,4-diolNSC66381Arranon (TN) (Glaxo Smith Kline)NSC132361NSC-132361SB19492DB-226463AB01273946-01

데이터베이스 식별자

CAS
121032-29-9、34793-34-5、7803-88-5
PubChem CID
248862
ChEMBL
CHEMBL1513356

물성

구조 계산 물성

XLogP
-0.7
극성 표면적
149 Ų
수소 결합 공여자 수
4
수소 결합 수용자 수
9
회전 가능 결합 수
3
무거운 원자 수
21
형식 전하
0
복잡도
377

물리화학적 성질

녹는점
209 · 209-217°
끓는 점
721 · 721.0±70.0 °C(Predicted)
밀도
1.98 · 1.98±0.1 g/cm3(Predicted)
저장 조건
2 · 2-8°C(protect from light)
용해도
DMSO(약간 용해됨), 메탄올(약간 용해됨, 가열), 물(약간 용해됨, 초음파 처리)
물리적 상태
고체
산도 계수 (pKa)
13.07 · 13.07±0.70(Predicted)
색상
하얀색
수용성
2 O: · H2O: 5mg/mL, clear (warmed)
InChI
InChI=1/C11H15N5O5/c1-20-9-5-8(14-11(12)15-9)16(3-13-5)10-7(19)6(18)4(2-17)21-10/h3-4,6-7,10,17-19H,2H2,1H3,(H2,12,14,15)/t4-,6-,7+,10-/s3
InChIKey
IXOXBSCIXZEQEQ-GCTRTDOSNA-N
SMILES
N1(C=NC2C(OC)=NC(N)=NC1=2)[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O1 |&1:12,13,15,17,r|

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

안전 데이터

wgk
WGK 3
스토리지 클래스
11 - Combustible Solids

화학 및 산업

응용 분야 · 2건

개요Nelarabine is a new member of the purine nucleoside antimetabolite class of drugs. It was launched as an intravenous infusion for treating relapsed or refractory T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) after at least two prior chemotherapy regimens. Nelarabine is a pro-drug of 9-b-D-arabinofuranosylguanine (ara-G), a deoxyguanosine derivative with a high level of T-cell selective cytotoxicity. Although Ara-G has been known since the 1960s, it has not been used in clinical studies due to its poor solubility. Nelarabine is the O-methyl derivative of ara-G with approximately 10 times greater aqueous solubility. It is demethylated in vivo by adenosine deaminase to produce ara-G, which is subsequently converted to the active 5’-triphosphate, ara-GTP. Accumulation of ara-GTP in leukemic blasts allows for incorporation into DNA, leading to inhibition of DNA synthesis and cell death.

용도A chemotherapy drug used in the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL).

추가 설명 · 1건

정의ChEBI: Nelarabine is a purine nucleoside in which O-methylguanine is attached to arabinofuranose via a beta-N(9)-glycosidic bond. Inhibits DNA synthesis and causes cell death; a prodrug of 9-beta-D-arabinofuranosylguanine (ara-G). It has a role as an antineoplastic agent, a DNA synthesis inhibitor and a prodrug. It is a purine nucleoside, a beta-D-arabinoside and a monosaccharide derivative. It is functionally related to a guanine and a 9-beta-D-arabinofuranosylguanine.

관련 반응

1건
반응 기록 만들기
HRID 213013 반응식
HRID 213013반응물로

화합물 노트

이 페이지에서기본 정보이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트